概括
经过冠状动脉旁路手术,经过心房动和先前心痛复苏的患者的存活率有所改善. 这种干预措施提供了一个更好的预后,与一般的存活率相比,这种心脏事件.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 干预心脏病学 干预心脏病学
背景情况:
- 意外心房动 (VF) 幸存者与先前的胸痛面临显著的长期死亡风险.
- 确定可治疗的冠状动脉疾病对于改善这些高风险患者的治疗结果至关重要.
研究的目的:
- 为了评估手术重血管化的疗效,在意外心室动后复苏的患者.
- 评估冠状动脉疾病患者在心脏骤停后接受旁路手术的长期生存率.
主要方法:
- 冠状动脉血管学和血液动力学评估在13名从VF恢复生命的患者中进行.
- 接受冠状动脉病变的患者提供了手术干预;11人中有8人接受了.
主要成果:
- 11名患者患有可以通过手术治疗的冠状动脉病变;8人接受了旁路手术.
- 手术后,患者存活了8-32个月 (平均24个月),与未经手术治疗的VF幸存者的1年死亡率约为30%形成鲜明对比.
- 在手术前观察到左心室末端透气压升高和心脏指数/排泄率压低.
结论:
- 在被选中的冠状动脉瘤幸存者中,冠状动脉瘤的冠状动脉旁路手术显著改善了长期的生存率.
- 应考虑对从意想不到的VF中恢复生命的患者进行手术重血管化,这些患者有显著的,可治疗的冠状动脉疾病.
相关概念视频
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


